CATHERINE MERCER: Open Payments
NPI 1902037252 · FORT SMITH, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$130 in 7 payments from 6 companies in 2025. Trend: 2023 $51 · 2024 $57 · 2025 $130
Food & beverage: $130
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $37 |
| Alexion Pharmaceuticals, Inc. | 1 | $27 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $18 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $17 |
| Exact Sciences Corporation | 1 | $16 |
| GlaxoSmithKline, LLC. | 1 | $14 |
Products named: STRENSIQ, XIFAXAN, AIRSUPRA, JARDIANCE, Cologuard Collection Kit, TRELEGY ELLIPTA.
Industry payments across AR — which companies pay providers there.
